HYDROCORTISONE ACETATE PRAMOXINE HYDROCHLORIDE PRAMOXINE HYDROCHLORIDE AND HYDROCORTISONE ACETATE NIVAGEN PHARMACEUTICALS INC. FDA Approved Hydrocortisone Acetate 2.5% Pramoxine HCl 1% Cream 2.5% is a topical preparation containing hydrocortisone acetate 2.5% w/w and pramoxine hydrochloride 1% w/w in a hydrophilic cream base containing stearic acid, cetyl alcohol, petrolatum, mineral oil, paraffin, microcrystalline wax, polyethylene wax, lanolin alcohol, isopropyl palmitate, polyoxyethylene 40 stearate, propylene glycol, potassium sorbate, sorbic acid, tea lauryl sulfate, and purified water. Topical corticosteroids are anti-inflammatory and anti-pruritic agents. The structural formula, the chemical name, molecular formula and molecular weight for active ingredients are presented below. hydrocortisone acetate Pregn-4-ene-3,20-dione, 21-(acetyloxy) -11,17-dihydroxy-, (11-beta) - C 23 H 32 O 6 ; mol. wt: 404.50 pramoxine hydrochloride 4-(3-(p-butoxyphenoxy) propyl) morpholine hydrochloride C 17 H 27 NO 3 .HCl; mol. wt: 329.87 Chemical Structure Chemical Structure
FunFoxMeds box
Route
TOPICAL
Package NDC

Drug Facts

Composition & Profile

Strengths
2.5 % 1 %
Treats Conditions
Indications And Usage Topical Corticosteroids Are Indicated For The Relief Of The Inflammatory And Pruritic Manifestations Of Corticosteroid Responsive Dermatoses

Identifiers & Packaging

Container Type BOX
All Product Codes
UPC
0375834197012
UNII
3X7931PO74 88AYB867L5
Packaging

HOW SUPPLIED Hydrocortisone Acetate 2.5% Pramoxine HCl 1% Cream 2.5% 1 oz tube (NDC 75834-197-01) Storage Conditions Store at 25ºC (77ºF); excursions permitted to 15-30ºC (59-86ºF) [see USP Controlled Room Temperature].; PRINCIPAL DISPLAY PANEL - 1 oz Tube Carton NDC 75834-197-01 Rx Only Hydrocortisone Acetate 2.5% Pramoxine HCl 1% Cream 2.5% NIVAGEN PHARMACEUTICALS Net Wt. 1 oz PRINCIPAL DISPLAY PANEL - 1 oz Tube Carton

Package Descriptions
  • HOW SUPPLIED Hydrocortisone Acetate 2.5% Pramoxine HCl 1% Cream 2.5% 1 oz tube (NDC 75834-197-01) Storage Conditions Store at 25ºC (77ºF); excursions permitted to 15-30ºC (59-86ºF) [see USP Controlled Room Temperature].
  • PRINCIPAL DISPLAY PANEL - 1 oz Tube Carton NDC 75834-197-01 Rx Only Hydrocortisone Acetate 2.5% Pramoxine HCl 1% Cream 2.5% NIVAGEN PHARMACEUTICALS Net Wt. 1 oz PRINCIPAL DISPLAY PANEL - 1 oz Tube Carton

Overview

Hydrocortisone Acetate 2.5% Pramoxine HCl 1% Cream 2.5% is a topical preparation containing hydrocortisone acetate 2.5% w/w and pramoxine hydrochloride 1% w/w in a hydrophilic cream base containing stearic acid, cetyl alcohol, petrolatum, mineral oil, paraffin, microcrystalline wax, polyethylene wax, lanolin alcohol, isopropyl palmitate, polyoxyethylene 40 stearate, propylene glycol, potassium sorbate, sorbic acid, tea lauryl sulfate, and purified water. Topical corticosteroids are anti-inflammatory and anti-pruritic agents. The structural formula, the chemical name, molecular formula and molecular weight for active ingredients are presented below. hydrocortisone acetate Pregn-4-ene-3,20-dione, 21-(acetyloxy) -11,17-dihydroxy-, (11-beta) - C 23 H 32 O 6 ; mol. wt: 404.50 pramoxine hydrochloride 4-(3-(p-butoxyphenoxy) propyl) morpholine hydrochloride C 17 H 27 NO 3 .HCl; mol. wt: 329.87 Chemical Structure Chemical Structure

Indications & Usage

Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Dosage & Administration

Topical corticosteroids are generally applied to the affected area as a thin film three to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

Warnings & Precautions
No warnings available yet.
Contraindications

Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Adverse Reactions

The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Itching Irritation Dryness Folliculitis Hypertrichosis Acneiform eruptions Hypopigmentation Perioral dermatitis Allergic contact dermatitis Maceration of the skin Secondary infection Skin atrophy Striae Miliaria

Storage & Handling

Storage Conditions Store at 25ºC (77ºF); excursions permitted to 15-30ºC (59-86ºF) [see USP Controlled Room Temperature].


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →